News
Come one, come all, Rivian is seemingly yelling at potential consumers as the company is bringing in spring with a new offer ...
Though it did beat expectations last quarter, the company's financial performance left much to be desired. Gross merchandise sales fell 6.5% year over year as less activity occurred on the platform.
Buffett is known for his long-term investment philosophies and willingness to hold winning stocks, even if they become significant portions of his portfolio. Just four winning stocks make up 57% of ...
With tariffs front of mind, investors are more focused on what is to come than on the recent results. On increased its full-year net sales outlook to "at least" 28% growth (on a constant-currency ...
Here's our initial take on JD.com 's ( JD 6.53%) fiscal 2025 first-quarter financial report.
Roku ( ROKU 12.97%) reported its 2025 first-quarter financial results not long ago. Revenue of just over $1 billion and the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
However, the negative returns of the Ark Innovation ETF show that the search for innovation will often result in negative returns. Although investors should still consider buying stocks leading the ...
Brookfield Renewable ( BEPC -0.09%) ( BEP 0.78%) has a terrific track record of growing value for its shareholders. One ...
Amplitude had a promising public offering, but the stock mostly struggled since 2022. After the recent acquisition, the company has finalized its platform, making its analytics software more ...
The VIX continues to fall below 19: The common market fear gauge moved to the lowest level since March 27. Improving investor ...
CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results